These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 4200420

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].
    Loubatières A, Mariani MM, Ribes G, de Malbosc H, Chapal J.
    Diabetologia; 1969 Feb; 5(1):1-10. PubMed ID: 4907149
    [No Abstract] [Full Text] [Related]

  • 44. Glybenclamid (HB 419) and the prediabetes of subtotally pancreatectomized rats.
    Goberna R, Fussgänger RD, Raptis S, Ditschuneit H, Pfeiffer EF.
    Horm Metab Res; 1969 Jul; 1(4):175-7. PubMed ID: 5003902
    [No Abstract] [Full Text] [Related]

  • 45. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
    Garcia-Barrado MJ, Jonas JC, Gilon P, Henquin JC.
    Eur J Pharmacol; 1996 Mar 18; 298(3):279-86. PubMed ID: 8846827
    [Abstract] [Full Text] [Related]

  • 46. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
    Rothenbuchner G, Raptis S, Pfeiffer EF.
    Wien Z Inn Med; 1973 Mar 18; 54(2):69-77. PubMed ID: 4203274
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
    Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, Yokoi N, Iwasaki M, Miki T, Seino S.
    Science; 2009 Jul 31; 325(5940):607-10. PubMed ID: 19644119
    [Abstract] [Full Text] [Related]

  • 51. Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.
    Bosboom RS, Zweens J, Bouman PR.
    Diabetologia; 1973 Aug 31; 9(4):243-50. PubMed ID: 4203349
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
    Alemany M, Palou A, Codina J, Herrera E.
    Diabete Metab; 1978 Sep 31; 4(3):181-6. PubMed ID: 101403
    [No Abstract] [Full Text] [Related]

  • 57. Effect of PGE2 on sulfonylurea induced insulin release.
    Villar A, Ivorra MD, Anselmi E.
    J Physiol (Paris); 1987 Sep 31; 82(1):12-7. PubMed ID: 3123643
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.